CD37 is a highly glycosylated transmembrane protein selectively expressed by normal B cells and the majority of B cell lymphomas and is specifically of interest for RIT, since CD37 receptor-antibody complexes are highly internalized in tumor cells5,6. The gene discussed is CD37; the disease is B-cell non-Hodgkin lymphoma.